atara
Bluelighter
I imagine that as with MDMA the demethylated cousin will be a not insignificant contributor to the effect profile.Typical phenethylamine SAR suggests that the compound should have very limited psychedelic activity (due to reduced 5ht2a agonism in comparison to 5apb), along with increased potency and selectivity for SERT. We'll see how this pans out. Surprises abound.
As for the compounds status as a new MDMA -- I suggest just trying to appreciate them for what they are. It will be more enjoyable that way.
And -next- time don't start with such a high dose of an unknown compound. >.>